S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TPST Tempest Therpeutics Inc

3.35

-0.01 (-0.30%)

Pre Market

Last Updated: 23:25:40

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Tempest Therpeutics (NASDAQ:TPST)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Tempest Therpeutics Charts.

Tempest Therpeutics (NASDAQ:TPST)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Tempest Therpeutics Charts.

Tempest Therpeutics Inc News

Tempest to Participate in Upcoming Investor Conferences
Tuesday 21 May 2024 (1 day ago) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Tuesday 14 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
Friday 10 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 10 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Saturday 27 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
Tuesday 9 April 2024 (1 month ago) • GlobeNewswire Inc.

Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
Thursday 4 April 2024 (2 months ago) • GlobeNewswire Inc.

Tempest Reports Year End 2023 Financial Results and Provides Business Update
Wednesday 20 March 2024 (2 months ago) • GlobeNewswire Inc.

Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
Wednesday 6 March 2024 (3 months ago) • GlobeNewswire Inc.

Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
Tuesday 27 February 2024 (3 months ago) • GlobeNewswire Inc.

More Tempest Therpeutics Inc News Articles

JP Morgan Chase

S&P ASX 300 Metals and M...

Australian SE All Ordina...

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions